109 related articles for article (PubMed ID: 36600852)
1. SARS-CoV-2 Omicron Variant in Patients With Chronic Lymphocytic Leukemia: Case Series.
Khamees I; Ali EA; Malkawi L; Rozi W; Yassin MA
Cureus; 2022 Nov; 14(11):e32041. PubMed ID: 36600852
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study.
Ali EA; Khamees I; Abu-Tineh M; Qasim H; Alshurafa A; Ahmed K; Malkawi L; Yassin MA
Cureus; 2022 Apr; 14(4):e23863. PubMed ID: 35411288
[TBL] [Abstract][Full Text] [Related]
3. A Case Series of SARS-CoV-2 Omicron Variant in Patients With Acute Leukemia.
Ali EA; Alamin MA; Abu-Tineh M; Ahmed K; Alshurafa A; Rozi W; Yassin MA
Cureus; 2022 May; 14(5):e25196. PubMed ID: 35747002
[TBL] [Abstract][Full Text] [Related]
4. Patients with CLL have a lower risk of death from COVID-19 in the Omicron era.
Niemann CU; da Cunha-Bang C; Helleberg M; Ostrowski SR; Brieghel C
Blood; 2022 Aug; 140(5):445-450. PubMed ID: 35588468
[TBL] [Abstract][Full Text] [Related]
5. Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Patients with Philadelphia-Negative Myeloproliferative Neoplasm: A Single Center Experience.
Ali EAH; Khamees I; Alshurafa A; Qasim H; Abu-Tineh MA; Ahmed K; Saad E; Yassin M
Oncology; 2022; 100(8):460-466. PubMed ID: 35882185
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues.
Kim S; Nguyen TT; Taitt AS; Jhun H; Park HY; Kim SH; Kim YG; Song EY; Lee Y; Yum H; Shin KC; Choi YK; Song CS; Yeom SC; Kim B; Netea M; Kim S
Immune Netw; 2021 Dec; 21(6):e38. PubMed ID: 35036025
[TBL] [Abstract][Full Text] [Related]
7. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
[TBL] [Abstract][Full Text] [Related]
8. Emergence of SARS-CoV-2 Omicron variant and strategies for tackling the infection.
Wu Y; Long Y; Wang F; Liu W; Wang Y
Immun Inflamm Dis; 2022 Dec; 10(12):e733. PubMed ID: 36444634
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics of Omicron SARS-CoV-2 Variant Infection After Non-mRNA-Based Vaccination in China.
Zeng QL; Lv YJ; Liu XJ; Jiang ZY; Huang S; Li WZ; Yu ZJ
Front Microbiol; 2022; 13():901826. PubMed ID: 35847120
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape.
Sanyaolu A; Marinkovic A; Prakash S; Haider N; Williams M; Okorie C; Badaru O; Smith S
World J Virol; 2022 May; 11(3):137-143. PubMed ID: 35665238
[TBL] [Abstract][Full Text] [Related]
11. [Omicron Variant of SARS-CoV-2 and Its Potential Impact on Dental Practice].
Ren B; Liao BY; Wang JN; Peng X; Zhou XD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 53(2):175-180. PubMed ID: 35332714
[TBL] [Abstract][Full Text] [Related]
12. Advances in the Omicron variant development.
Vitiello A; Ferrara F; Auti AM; Di Domenico M; Boccellino M
J Intern Med; 2022 Jul; 292(1):81-90. PubMed ID: 35289434
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features of 19 children infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 in Hangzhou, China].
Qi ZH; Bei ZF; Teng S; Wang HP; Li W; Zhao SY; Liu SR
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1092-1097. PubMed ID: 36305108
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Omicron variant: recent progress and future perspectives.
Fan Y; Li X; Zhang L; Wan S; Zhang L; Zhou F
Signal Transduct Target Ther; 2022 Apr; 7(1):141. PubMed ID: 35484110
[TBL] [Abstract][Full Text] [Related]
15. An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.
Paz M; Aldunate F; Arce R; Ferreiro I; Cristina J
Virus Res; 2022 Jun; 314():198753. PubMed ID: 35331836
[TBL] [Abstract][Full Text] [Related]
16. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468
[TBL] [Abstract][Full Text] [Related]
17. Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant.
Boscolo-Rizzo P; Tirelli G; Meloni P; Hopkins C; Madeddu G; De Vito A; Gardenal N; Valentinotti R; Tofanelli M; Borsetto D; Lechien JR; Polesel J; De Riu G; Vaira LA
Int Forum Allergy Rhinol; 2022 Oct; 12(10):1273-1281. PubMed ID: 35286777
[TBL] [Abstract][Full Text] [Related]
18. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
Front Immunol; 2022; 13():940562. PubMed ID: 36091023
[TBL] [Abstract][Full Text] [Related]
19. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
[TBL] [Abstract][Full Text] [Related]
20. Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study.
Mauro FR; Giannarelli D; Galluzzo CM; Visentin A; Frustaci AM; Sportoletti P; Vitale C; Reda G; Gentile M; Levato L; Murru R; Armiento D; Molinari MC; Proietti G; Pepe S; De Falco F; Mattiello V; Barabino L; Amici R; Coscia M; Tedeschi A; Girmenia C; Trentin L; Baroncelli S
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
